Acasti Pharma Inc. (NASDAQ:ACST) has a beta value of 0 and has seen 1,444,609 shares traded in the last trading session. The company, currently valued at $70.48 Million, closed the last trade at $0.77 per share which meant it lost -$0.02 on the day or -1.9% during that session. The ACST stock price is -300% off its 52-week high price of $3.08 and 67.53% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.22 Million shares traded. The 3-month trading volume is 2.89 Million shares.

The consensus among analysts is that Acasti Pharma Inc. (ACST) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 4 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.16.

Acasti Pharma Inc. (NASDAQ:ACST) trade information

Despite being -1.9% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Aug 07 when the ACST stock price touched $0.815 or saw a rise of 5.52%. Year-to-date, Acasti Pharma Inc. shares have moved -68.57%, while the 5-day performance has seen it change -2.3%. Over the past 30 days, the shares of Acasti Pharma Inc. (NASDAQ:ACST) have changed 8.7%. Short interest in the company has seen 646.02 Million shares shorted with days to cover at 223.54.

Wall Street analysts have a consensus price target for the stock at $2.9, which means that the shares’ value could jump 276.62% from current levels. The projected low price target is $0.99 while the price target rests at a high of $7. In that case, then, we find that the current price level is +809.09% off the targeted high while a plunge would see the stock lose 28.57% from current levels.

Acasti Pharma Inc. (ACST) estimates and forecasts

Earnings growth for 2020 is a modest +30.3%.